These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea. Mohan RR; Sinha S; Tandon A; Gupta R; Tovey JC; Sharma A PLoS One; 2011 Apr; 6(4):e18771. PubMed ID: 21533273 [TBL] [Abstract][Full Text] [Related]
4. Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access. Mohan RR; Schultz GS; Hong JW; Mohan RR; Wilson SE Exp Eye Res; 2003 Mar; 76(3):373-83. PubMed ID: 12573666 [TBL] [Abstract][Full Text] [Related]
5. Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy. Liu J; Saghizadeh M; Tuli SS; Kramerov AA; Lewin AS; Bloom DC; Hauswirth WW; Castro MG; Schultz GS; Ljubimov AV Mol Vis; 2008; 14():2087-96. PubMed ID: 19023450 [TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated gene transfer of interleukin 10 to the ovine and human cornea. Parker DG; Coster DJ; Brereton HM; Hart PH; Koldej R; Anson DS; Williams KA Clin Exp Ophthalmol; 2010 May; 38(4):405-13. PubMed ID: 20491805 [TBL] [Abstract][Full Text] [Related]
8. Efficient Transduction of Corneal Stroma by Adeno-Associated Viral Serotype Vectors for Implications in Gene Therapy of Corneal Diseases. Lu Y; Ai J; Gessler D; Su Q; Tran K; Zheng Q; Xu X; Gao G Hum Gene Ther; 2016 Aug; 27(8):598-608. PubMed ID: 27001051 [TBL] [Abstract][Full Text] [Related]
9. Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy. Mohan RR; Tandon A; Sharma A; Cowden JW; Tovey JC Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4833-41. PubMed ID: 21551414 [TBL] [Abstract][Full Text] [Related]
10. Suppression of alkali-induced oxidative injury in the cornea by mesenchymal stem cells growing on nanofiber scaffolds and transferred onto the damaged corneal surface. Cejkova J; Trosan P; Cejka C; Lencova A; Zajicova A; Javorkova E; Kubinova S; Sykova E; Holan V Exp Eye Res; 2013 Nov; 116():312-23. PubMed ID: 24145108 [TBL] [Abstract][Full Text] [Related]
11. Gene transfer to ex vivo stored corneas. Fehervari Z; Rayner SA; Oral HB; George AJ; Larkin DF Cornea; 1997 Jul; 16(4):459-64. PubMed ID: 9220245 [TBL] [Abstract][Full Text] [Related]
12. Corneal wound healing is modulated by topical application of amniotic fluid in an ex vivo organ culture model. Castro-Combs J; Noguera G; Cano M; Yew M; Gehlbach PL; Palmer J; Behrens A Exp Eye Res; 2008 Jul; 87(1):56-63. PubMed ID: 18555991 [TBL] [Abstract][Full Text] [Related]
14. Effect of ex vivo gene transfer with an adenoviral vector on human eye bank corneas. Thiel MA; Saydam C; Pavlovic J; Hemmi S Ophthalmic Res; 2005; 37(2):67-71. PubMed ID: 15746561 [TBL] [Abstract][Full Text] [Related]
15. Safety profile of topical VEGF neutralization at the cornea. Bock F; Onderka J; Rummelt C; Dietrich T; Bachmann B; Kruse FE; Schlötzer-Schrehardt U; Cursiefen C Invest Ophthalmol Vis Sci; 2009 May; 50(5):2095-102. PubMed ID: 19151400 [TBL] [Abstract][Full Text] [Related]
16. RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing. Wilson SE; Mohan RR; Netto M; Perez V; Possin D; Huang J; Kwon R; Alekseev A; Rodriguez-Perez JP Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2201-11. PubMed ID: 15223796 [TBL] [Abstract][Full Text] [Related]
17. Six-Month In Vivo Safety Profiling of Topical Ocular AAV5-Decorin Gene Transfer. Mohan RR; Balne PK; Muayad MS; Tripathi R; Sinha NR; Gupta S; An JA; Sinha PR; Hesemann NP Transl Vis Sci Technol; 2021 Aug; 10(10):5. PubMed ID: 34383877 [TBL] [Abstract][Full Text] [Related]
18. New strategy for in vivo transgene expression in corneal epithelial progenitor cells. Igarashi T; Miyake K; Suzuki N; Kato K; Takahashi H; Ohara K; Shimada T Curr Eye Res; 2002 Jan; 24(1):46-50. PubMed ID: 12187494 [TBL] [Abstract][Full Text] [Related]